23 and Me

Join Our Mailing List

Personal DNA Analysis and Reporting 

[By Staff Reporters]

Ever wondered why you were left-handed and your sibling or parent wasn’t?

A not-so-new new company, 23andMe, provides an analysis of DNA, where you can learn more about yourself, your immediate family and even your ancestry.

Target Markets

Those who would be especially interested in this personal genome service include:

Methodology

Customers [sic patients] submit a small saliva sample that is processed using a proprietary custom DNA chip. The resulting data is then presented on a secure website using interactive tools that offer information about ancestry, inherited traits and disease risk.

Board of Directors

This is no lightweight company. It technology founders include:

  • Linda Avey
  • Anne Wojcicki
  • Esther Dyson

While its’ medical advisors are:

  • Uta Francke; MD [Professor of Genetics and Pediatrics, Stanford University].
  • Itsik Pe’er; PhD [Assistant Professor of Computer Science, Columbia University].
  • Peter A. Underhill; PhD [Senior Research Scientist, Stanford University].

Assessment

You can also better understand your genetic tendencies for things like obesity or health issues.

There is even an interactive blog: http://spittoon.23andme.com

Users can find other members with similar genetic makeup and start discussions. And, it is $999 to order a kit for the DNA test. 

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

DICTIONARIES: http://www.springerpub.com/Search/marcinko
PHYSICIANS: www.MedicalBusinessAdvisors.com
PRACTICES: www.BusinessofMedicalPractice.com
HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
CLINICS: http://www.crcpress.com/product/isbn/9781439879900
ADVISORS: www.CertifiedMedicalPlanner.org
PODIATRISTS: www.PodiatryPrep.com
BLOG: www.MedicalExecutivePost.com
FINANCE: Financial Planning for Physicians and Advisors
INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors

Product DetailsProduct DetailsProduct Details

12 Responses

  1. 23andMe

    23andMe just dropped their core price down to $399 and have inked a deal to get access to Ancestry.com’s database of users. Not quite an impulse purchase yet, but still getting down there.

    Ann

    Like

  2. Publicity for 23andMe

    According to journalist Matthew Holt, Sergey Brin, Google co-founder and husband of 23andMe co-founder Anne Wojcicki, has announced that he has the gene for Parkinson’s disease and that his mother carries it to. She already has the disease, as did her aunt.

    Sergey has written about this on his new blog “Too” and it was picked up by the NY Times. Fortunately, if—and it’s only an “if”—Brin develops Parkinson’s it’ll be many years from now.

    However, Parkinson’s is a very serious condition which people are right to dread.

    Anonymous

    Like

  3. To Sergey Brin

    Here is the blog and link [LRRK2] for Sergey Brin.
    http://too.blogspot.com/2008/09/lrrk2.html

    Hope Rachel Hetico RN MHA
    [Managing Editor]

    Like

  4. Genetic Testing and Insurance
    [One Datum]

    Reductions in the cost of genetic testing and improvements in what we know about what it tells us produce obvious benefits; if you know you are likely to have some particular medical problem, you may be able to take precautions against it.

    But, they also have at least one potential downside.

    An essay by David Friedman:

    http://thehealthcareblog.com/blog/2012/02/03/genetic-testing-and-insurance-one-datum/

    Kathy

    Like

  5. Company Gets Patent To Create Designer Babies

    Thanks to personal genomics companies like 23andMe, it’s becoming quicker and easier for us to find out who we are.

    http://www.theverge.com/2013/10/2/4795586/23andme-designer-baby-patent?utm_source=Copy+of+10.3.13&utm_campaign=11713&utm_medium=email

    But, will the same technology one day allow us to decide who our babies will be – before they’re even born?

    That’s the question raised by a newly issued patent, which grants 23andMe rights to a system that allows parents to pick and choose their children’s traits prior to undergoing fertility treatment.

    Hope R. Hetico RN MHA

    Like

  6. Hope,

    I have been seeing TV commercial promoting 23andMe; just recently.
    I am in Cleveland, Ohio.

    Akee

    Like

  7. DDA Tells Google to Stop Selling DNA Kits

    In a crackdown on genetic testing that is offered directly to consumers, the FDA has demanded that 23andMe immediately cease selling and marketing its DNA testing service until it receives clearance from the agency.

    In a scathing warning letter that the agency posted on its website, it said that 23andMe had failed to provide adequate evidence that its product, Personal Genome Service, provided accurate results. The “F.D.A. is concerned about the public health consequences of inaccurate results from the P.G.S. device”.

    Hope R. Hetico RN MHA

    Like

  8. 23andMe

    Stopping 23andMe Will Only Delay the Revolution Medicine Needs.

    http://thehealthcareblog.com/blog/2013/11/29/stopping-23andme-will-only-delay-the-revolution-medicine-needs/

    Selma

    Like

  9. 23andMe

    The FDA halted the plans of 23andMe’s to decode the genomic data of a million Americans.

    Still the CEO – Anne Wojcicki – vows to press on in an attempt to transform the American way of delivering healthcare.

    Sanjay

    Like

  10. Genetic Testing and Employee Health

    Your employer may one day help determine if your genes are why your jeans have become too snug.

    http://www.msn.com/en-us/money/companies/genetic-testing-moves-into-world-of-employee-health/ar-BBiMiLW?ocid=iehp

    Gershem

    Like

  11. 23 and Me 2017 Update

    The Food and Drug Administration approved the first-ever direct-to-consumer genetic testing for people’s personal risk of contracting 10 potentially serious conditions including late-onset Alzheimer’s, Parkinson’s disease, celiac disease and a hereditary blood-clot condition called thrombophilia.

    http://www.msn.com/en-us/money/companies/fda-approves-23andmes-genetic-test-for-personal-disease-risks/ar-BBzvauF?li=BBnbfcN

    Dr. David Marcinko MBA

    Like

  12. 23 and Me

    5 biggest risks of sharing your DNA with consumer genetic-testing companies.

    http://www.msn.com/en-us/money/companies/5-biggest-risks-of-sharing-your-dna-with-consumer-genetic-testing-companies/ar-AAyJfPr?li=BBnb7Kz

    Dr. David E. Marcinko MBA

    Liked by 1 person

Leave a comment